Public organizations — lung adenocarcinoma and lung cancer
Last verified: 2026-08-29
Every URL below was fetched live on the access date and returned HTTP 200. Scope descriptions are paraphrases of public-facing material. The table does not rank quality or imply endorsement.
Global and multi-country
| Organization |
Geography |
Public focus relevant to adenocarcinoma |
URL |
Access |
| International Association for the Study of Lung Cancer |
Global |
Professional/patient education, research, conferences, staging and pathology resources |
iaslc.org |
2026-08-29 |
| Global Lung Cancer Coalition |
Global coalition |
International patient-organization collaboration, awareness, research and access |
lungcancercoalition.org |
2026-08-29 |
| Lung Cancer Europe |
Europe |
Umbrella patient advocacy, policy, access, research participation and awareness |
lungcancereurope.eu |
2026-08-29 |
United States and molecular communities
| Organization |
Geography |
Public focus relevant to adenocarcinoma |
URL |
Access |
| GO2 for Lung Cancer |
United States/national |
Support, helpline, screening, treatment education, advocacy and research |
go2.org |
2026-08-29 |
| LUNGevity Foundation |
United States/national |
Education, support, research funding, biomarkers and survivorship |
lungevity.org |
2026-08-29 |
| Lung Cancer Research Foundation |
United States/national |
Research funding, education, patient resources and advocacy |
lungcancerresearchfoundation.org |
2026-08-29 |
| ALK Positive |
International community, US-based nonprofit |
ALK-positive peer support, research funding, education and trial awareness |
alkpositive.org |
2026-08-29 |
| EGFR Resisters |
International community, US-based nonprofit |
EGFR-positive education, research collaboration, advocacy and peer community |
egfrcancer.org |
2026-08-29 |
| The ROS1ders |
International molecular community |
ROS1-positive patient/research collaboration and education |
theros1ders.org |
2026-08-29 |
United Kingdom, Canada, and Australia
| Organization |
Geography |
Public focus relevant to adenocarcinoma |
URL |
Access |
| Roy Castle Lung Cancer Foundation |
United Kingdom |
Prevention, early detection, patient information, support and research |
roycastle.org |
2026-08-29 |
| Lung Cancer Canada |
Canada |
Education, support, advocacy, research and national access issues |
lungcancercanada.ca |
2026-08-29 |
| Lung Foundation Australia |
Australia |
Lung-disease and lung-cancer support, information, policy and research |
lungfoundation.com.au |
2026-08-29 |
How to use this directory
| Need |
Directory role |
Verification still required |
| General education |
Identify public learning resources |
Date, jurisdiction, medical-review process |
| Molecular peer community |
Locate genotype-specific support |
Privacy rules, moderation, scientific review |
| Trial navigation |
Find questions and referral resources |
ClinicalTrials.gov status and site-level availability |
| Financial/logistical support |
Identify possible programs |
Eligibility, geography, funding, current availability |
| Advocacy participation |
Locate public campaigns |
Data-use and consent terms |
Known coverage gaps
- Few independently verified organizations from Africa, Latin America, the Middle East, and much of Asia are represented here.
- English-language web accessibility shaped discovery.
- Molecular communities for RET, MET, BRAF, KRAS, HER2, and NTRK were not separately catalogued when a stable independent organization could not be verified in this session.
- Organization reach, governance, moderation quality, and accessibility were not audited.
Re-verification checklist
- [ ] URL resolves without unsafe redirect.
- [ ] Organization identity and geography remain clear.
- [ ] Public privacy and community rules are visible before referral.
- [ ] Trial listings are cross-checked against ClinicalTrials.gov.
- [ ] Medical content shows a review/update date where possible.
- [ ] Services are not assumed available outside the stated region.